Selective lethal effect of thymidine on human and mouse tumor cells

Area of Science:

• Cell Biology
• Cancer Research
• Biochemistry

Background:

• Investigating differential cellular responses to thymidine is crucial for understanding cancer biology.
• Normal human and mouse cell lines, alongside human tumor cell lines, were utilized to compare thymidine sensitivity.

Purpose of the Study:

• To quantitatively assess the sensitivity of various human and mouse cell lines to thymidine in tissue culture.
• To determine if thymidine sensitivity correlates with tumor-forming capabilities in vivo.

Main Methods:

• Quantitative study of cell lines (melanoma, colon carcinoma, melanocytes, intestinal epithelial cells, mouse mesenchymal cells) in tissue culture.
• Assessment of cell survival and colony formation after exposure to high concentrations of thymidine (1 mg/ml for 72 hours).
• Tumorigenicity assay by injecting cell lines into nude thymus-deficient mice.

Main Results:

• Tumorigenic cell lines (human melanoma, colon carcinoma, and a malignant mouse subline) produced tumors in mice.
• Non-tumorigenic cell lines did not form tumors.
• Tumorigenic cell lines exhibited significantly greater sensitivity to thymidine, with less than 23% survival compared to over 60% for non-tumorigenic cells after 72 hours. Colony formation was also more severely inhibited in tumor cells.

Conclusions:

• Tumorigenic cell lines demonstrate a heightened sensitivity to lethal concentrations of thymidine compared to their non-tumorigenic counterparts.
• The differential sensitivity to thymidine suggests a potential therapeutic window for targeting cancer cells.
• Thymidine's inhibitory effect on colony formation further supports its potential as an anti-cancer agent.